Long COVID as a Mass Disability Event: Biological Mechanisms, Economic Consequences, and the Rehabilitation Imperative

Abstract

The COVID-19 pandemic left behind a chronic condition whose scale qualifies it as one of the largest disability events in modern history. Long COVID, or post-COVID-19 condition, affects a meaningful fraction of those infected with SARS-CoV-2 and produces fatigue, cognitive impairment, and respiratory limitation that can persist for years, fluctuate unpredictably, and remove otherwise healthy adults from work at the peak of their productive lives. This paper joins a biological and an economic reading of the phenomenon and asks what both imply for rehabilitation and disability policy. We first synthesise the mechanistic evidence, viral persistence, immune dysregulation, endothelial injury, and autonomic dysfunction, that has moved long COVID from contested syndrome to documented multi- system disease. We then assemble the economic evidence: population-level estimates of symptom-cluster prevalence, labour-market withdrawal on the order of millions of workers in the United States alone, and aggregate cost estimates in the trillions of dollars once foregone earnings, medical spending, and lost wellbeing are counted. A simple accounting framework formalises these components, and we discuss what its terms look like in low- and middle- income countries, where surveillance is weakest, rehabilitation capacity thinnest, and the condition largely invisible in official statistics. We argue that long COVID exposes a structural mismatch between episodic, fluctuating disability and rehabilitation and benefit systems built for stable diagnoses, and that the response, multidisciplinary rehabilitation, paced self-management, telehealth, and disability recognition, is affordable relative to the cost of inaction. Recommendations are offered for health systems, employers, and researchers.